Stay updated on Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Minor revision update from v3.4.0 to v3.4.1; no changes to study content, data, or page functionality are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:01:19.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added a glossary toggle and new metadata fields (Last Update Submitted that Met QC Criteria, No FEAR Act Data) with Revision: v3.4.0. Removed older/duplicate metadata terms (Last Update Submitted that met QC Criteria, No FEAR Act data) and related references (e.g., MedlinePlus Genetics).
    Difference
    0.3%
    Check dated 2026-01-28T21:44:02.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Removed related topics Melanoma and MedlinePlus Genetics, and added Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-14T04:43:16.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and MedlinePlus Genetics as related topics on the study page.
    Difference
    0.1%
    Check dated 2025-12-31T00:46:23.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added a Locations section listing New South Wales, Queensland, and Victoria, and updated the page revision to v3.3.3. Removed separate state location subpages (New South Wales Locations, Queensland Locations, Victoria Locations) and withdrew certain footer/related-topic links (HHS Vulnerability Disclosure, Melanoma, MedlinePlus Genetics).
    Difference
    0.5%
    Check dated 2025-12-23T22:50:27.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Added Melanoma and MedlinePlus Genetics as related topics and updated the auto-generated PubMed publication note to Revision: v3.3.2. Deleted the previous PubMed publication note and Revision: v3.2.0.
    Difference
    0.2%
    Check dated 2025-11-25T14:16:02.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page.